Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c

Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c

Bibliographic Details
Main Authors: BSE August-Jörg, R Hermann, M Weitz, E Renner
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2003-08-01
Series:Swiss Medical Weekly
Subjects:
SASL
Ribavirin
Interferonalpha
combination therapy
Relapse
Hepatitis C
Online Access:https://www.smw.ch/index.php/smw/article/view/299
Description
ISSN:1424-3997

Similar Items